• Posted: March 18, 2015 Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma.

    Lendvai N, Cohen AD, Cho HJ.

    READ MORE
  • Posted: March 18, 2015 Metabolic signature identifies novel targets for drug resistance in Multiple...

    Maiso P, Huynh D, Moschetta M, Sacco A, Aljawai Y, Mishima Y, Asara JM, Roccaro AM, Kimmelman AC, Ghobrial IM.

    READ MORE
  • Posted: March 16, 2015 REVLIMID® (Lenalidomide) Approved by the European Commission for the Treatment...

    BOUDRY, Switzerland--(BUSINESS WIRE)-- Celgene International Sàrl, a wholly owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that the...

    READ MORE
  • Posted: March 16, 2015 PHASE 3 HEAD-TO-HEAD ENDEAVOR STUDY DEMONSTRATES SUPERIORITY OF KYPROLIS®...

    THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif., March 1, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and its subsidiary Onyx Pharmaceuticals, Inc., today...

    READ MORE
  • Posted: February 17, 2015 Cancer Blows: A Declaration of Defiance Against Multiple Myeloma

    The call came on a day leading up to his stem cell transplant. Ryan Anthony had just been diagnosed with multiple myeloma, and his friend and fellow musician,...

    READ MORE
  • Posted: February 17, 2015 Impact of Pretransplant Therapy and Depth of Disease Response before Autologous...

    Vij R, Kumar S, Zhang MJ, Zhong X, Huang J, Dispenzieri A, Abidi MH, Bird JM, Freytes CO, Gale RP, Kindwall-Keller TL, Kyle RA, Landsburg DJ, Lazarus HM,...

    READ MORE
  • Posted: February 17, 2015 CyBorD induction therapy in clinical practice

    Areethamsirikul N, Masih-Khan E, Chu CM, Jimenez-Zepeda V, Reece DE, Trudel S, Kukreti V, Tiedemann R, Chen C.

    READ MORE
  • Posted: February 17, 2015 An open label phase I/II study of cyclophosphamide, bortezomib, pegylated...

    Nishihori T, Baz R, Shain K, Kim J, Ochoa-Bayona JL, Yue B, Sullivan D, Dalton W, Alsina M

    READ MORE
  • Posted: February 17, 2015 Role of Magnetic Resonance Imaging in the Management of Patients With Multiple...

    Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, Raje N, Sezer O, Zweegman S, Shah J, Badros A, Shimizu K, Moreau P, Chim CS, Lahuerta...

    READ MORE
  • Posted: February 17, 2015 Minimal residual disease in multiple myeloma: bringing the bench to the bedside

    Mailankody S, Korde N, Lesokhin AM, Lendvai N, Hassoun H, Stetler-Stevenson M, Landgren O.

    READ MORE

Page 22/15